Medical Disclaimer: We are not doctors, pharmacists, or medical professionals, and nothing in this comparison is medical advice. This is independent editorial content for informational purposes only. GLP-1 medications are prescription-only — a licensed clinician determines eligibility and which medication, if any, is appropriate. Compounded medications are not FDA-approved. Individual results vary, and weight loss is never guaranteed.
Affiliate Disclosure: Some links on this page may earn us a commission at no extra cost to you. Commissions never influence a verdict.
Before you compare any two GLP-1 telehealth programs, there’s a bigger face-off to settle: compounded vs. brand-name medication. It’s the choice that determines whether you’re budgeting $150 or $1,300 a month — and it’s a choice with real differences in regulatory oversight that deserve a clear-eyed comparison, not marketing spin from either side.
The contenders
In the brand-name corner: Ozempic and Wegovy (semaglutide, Novo Nordisk) and Mounjaro and Zepbound (tirzepatide, Eli Lilly) — FDA-approved finished products, manufactured on controlled lines, validated by the large clinical trials that made this drug class famous. In the compounded corner: semaglutide and tirzepatide prepared by licensed U.S. compounding pharmacies (state-regulated 503A pharmacies or FDA-registered 503B facilities) on individual prescriptions — the backbone of nearly every affordable telehealth program, from TrimRX and Wellorithm to Brightmeds and AltRx.
Round 1: Price
No contest, and it’s why this face-off exists. Brand-name GLP-1s retail around $900–$1,350 per month without insurance — Wegovy sits near $1,349. Compounded plans at major telehealth platforms currently start between $147 and $189 per month for semaglutide and $249–$400 for tirzepatide. Over a realistic 12-month treatment window, that’s the difference between roughly $2,000–$4,000 and $11,000–$16,000. Manufacturer savings programs and insurance coverage can shrink the gap substantially — always check both — but at raw cash prices, this round is a knockout. Winner: Compounded.
Round 2: Regulatory oversight
Equally decisive in the other direction. Brand-name products carry FDA approval: the finished product’s safety, effectiveness, and manufacturing quality were federally reviewed before sale. Compounded medications are legal and prepared under state and federal pharmacy regulation, but the finished compounded product itself is never FDA-reviewed or approved — a sentence responsible platforms like Wellorithm print on their own websites. The FDA has also flagged real-world concerns with some compounded GLP-1 products: dosing errors from multi-dose vials, refrigeration lapses in shipping, and some products built on semaglutide salt forms that aren’t the same active ingredient studied in the trials. Pharmacy quality varies, which is exactly why it must be verified. Winner: Brand-name.
Round 3: Access and convenience
Brand-name access often means insurance prior authorizations, step therapy, periodic shortages, and pharmacy runs. Compounded telehealth means an online intake, clinician review in hours to days, and medication at your door within a week — the friction difference is a major reason the compounded market exploded. Winner: Compounded.
Round 4: Predictability
With brand-name, you know exactly what’s in the pen — but your price can be unpredictable, hostage to insurance decisions and coverage changes. With compounded, pricing is published and stable (TrimRX even holds price flat across doses), but product consistency depends on the pharmacy behind it. Call this round a split decision that comes down to which uncertainty you’d rather manage. Winner: Draw.
The verdict
Brand-name fits you if insurance covers it, you qualify for manufacturer programs, or federal approval of the exact product you inject is non-negotiable — a completely reasonable position. Compounded fits you if you’re paying cash, brand-name pricing is simply out of reach, and you do the vetting: a platform that names its 503A/503B pharmacy partners, ships temperature-controlled, states the FDA status plainly, and ideally carries third-party certification like LegitScript. Skip both if a licensed clinician hasn’t evaluated whether GLP-1 treatment is appropriate for you — that’s the gate everything else waits behind.
Ready to compare actual programs? Start with our four-provider head-to-head, then the individual face-offs: TrimRX vs. Brightmeds and Wellorithm vs. AltRx.